@cspramesh @ParikhSimul According to the NEJM for the number one cancer killer (lung) it’s medical oncology (for living longer) https://t.co/hVTuGBpJ4V.
@5_utr @CGrassberger @HenningWillers @PatrickCMa1 @PercyLeeMD @SalmaJabbour1 @SBRT_CR @BLoo_LT_SABR @TimothyKruserMD @abewu Notice my careful wording :) doubt the improvement in stage IV nsclc is VERY MUCH from RT Nay, not doubt I *know* stage IV surviva
@ManniMD1 @DrNikitaMehra @AaronGoodman33 @BlairDeStefano @rajshekharucms @HadidiSamer @Eddie_Cliff @Dr_AmerZeidan @sghmd @MyelomaAmateur @MyelomaTeacher The delay in action by these Medical Ivory Towers was so great, that it may have impacted the overall C
@tnewsomdavis @JackWestMD @PatelOncology @bradloncar @US_FDA Tom, do you think the delay (maybe perceived) in targeted therapy (& IO) availability has had an impact on population outcomes for NSCLC in UK? The use of targeted therapy/IO in US is being
@JAMANetworkOpen @RajaFlores Nope. Mortality is not same as "incidence based mortality" (what was measured). Stage shift (reduced rate of advanced dz) is not the same as stage proportions (what was measured). And how can trend be caused by '06 pub when vis
@Isabelalor2015 @albertoruano8 Perdona Isabel, pensaba que hay puesto el link de acceso al cuerpo del artículo. 🔗 https://t.co/449age3dxq
Still long way to go for SCLC @atstoa @NEJM
RT @VivekSubbiah: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/A5gjjEslF9
RT @VivekSubbiah: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/A5gjjEslF9
RT @VivekSubbiah: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/A5gjjEslF9
The Effect of Advances in Lung-Cancer Treatment on Population Mortality @NEJM https://t.co/A5gjjEslF9
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/A5gjjEslF9
This is interesting clue as well, improvements in lung cancer outcomes (prevention and treatment) now driving improvements in US cancer outcomes https://t.co/1KttmkmPrp.
@MartinStockler @CraigUnderhill @TommyJohn00 @BelindaKiely @TrialsCentre Important further caveat for docs using this for lung cancer is that SEER data showed significant improvements in mortality for NSCLC (adenocarcinoma) between 2013 and 2016. Need to m
@CodiceViola @lucfontana @Corriere Per la prima volta negli USA si è visto, dopo l'introduzione dei farmaci target nel polmone, una riduzione della mortalità maggiore della riduzione dell'incidenza. Quindi non solo meno fumo, ma anche terapie più efficaci.
RT @EricEngelsMD: Interesting study in @NEJM: #lungcancer mortality has declined over 2 decades in US, faster than incidence. This pattern…
@SoniaVilla88 Ha costado muchos años pero por fin se empiezan a ver los efectos de la investigación. Por primera vez se muestra un descenso en la mortalidad por cáncer de pulmón en Estados Unidos. ¡Y más por venir! https://t.co/449agekOoY https://t.co/YKN
RT @FrentePulmonMx: La mortalidad por #CáncerDePulmón microcítico en los EUA disminuyó de 2013 a 2016 y la supervivencia después del diagnó…
La mortalidad por #CáncerDePulmón microcítico en los EUA disminuyó de 2013 a 2016 y la supervivencia después del diagnóstico mejoró sustancialmente. Un análisis sugiere que el uso de terapias dirigidas podría explicar la reducción de mortalidad observada.
RT @toddscarbrough: @hbar2div2m @DrChowdharyMD @CAonline @AmericanCancer @CancerGeek @RushCancer @OncoAlert Lung: Immunotx! (and less smoki…
@hbar2div2m @DrChowdharyMD @CAonline @AmericanCancer @CancerGeek @RushCancer @OncoAlert Lung: Immunotx! (and less smoking) https://t.co/py8wQcHKjr
RT @VivekSubbiah: 14. The Effect of Advances in Lung-Cancer Treatment on Population Mortality @NEJM https://t.co/XH0xZtI4hv
RT @VivekSubbiah: 14. The Effect of Advances in Lung-Cancer Treatment on Population Mortality @NEJM https://t.co/XH0xZtI4hv
14. The Effect of Advances in Lung-Cancer Treatment on Population Mortality @NEJM https://t.co/XH0xZtI4hv
RT @CHESTOncology: Decrease in incidence + Treatment advances > Decreased NSCLC related mortality! @accpchest #ChestOnc https://t.co/b0p…
RT @CHESTOncology: Decrease in incidence + Treatment advances > Decreased NSCLC related mortality! @accpchest #ChestOnc https://t.co/b0p…
Decrease in incidence + Treatment advances > Decreased NSCLC related mortality! @accpchest #ChestOnc https://t.co/b0pg3AaPWw
RT @CHESTOncology: Population-level mortality from NSCLC in the United States fell sharply from 2013 to 2016, & survival after diagnosis im…
RT @BrendonStilesMD: T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding inc…
RT @BrendonStilesMD: T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding inc…
RT @CHESTOncology: Population-level mortality from NSCLC in the United States fell sharply from 2013 to 2016, & survival after diagnosis im…
RT @CHESTOncology: Population-level mortality from NSCLC in the United States fell sharply from 2013 to 2016, & survival after diagnosis im…
RT @CHESTOncology: Population-level mortality from NSCLC in the United States fell sharply from 2013 to 2016, & survival after diagnosis im…
Population-level mortality from NSCLC in the United States fell sharply from 2013 to 2016, & survival after diagnosis improved substantially across all races and ethnic groups. Research suggests through targeted therapies & decreased incidence. #CH
RT @BrendonStilesMD: T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding inc…
Progress sorely needed #Lcsm For our patients. Good news indeed
RT @christinemphmd: Encouraging to see therapy options for patients with #lungcancer improving each year! #lcsm @lcsmchat
RT @christinemphmd: Encouraging to see therapy options for patients with #lungcancer improving each year! #lcsm @lcsmchat https://t.co/sYe…
Encouraging to see therapy options for patients with #lungcancer improving each year! #lcsm @lcsmchat
RT @BrendonStilesMD: T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding inc…
RT @BrendonStilesMD: T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding inc…
RT @BrendonStilesMD: T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding inc…
RT @BrendonStilesMD: T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding inc…
RT @CharuAggarwalMD: Yes, this was HUGE. BUT, the data hasn't taken the effects of immunotherapy into account, yet. We expect the survival…
Yes, this was HUGE. BUT, the data hasn't taken the effects of immunotherapy into account, yet. We expect the survival gains to continue to increase over the next several years! #LCSM
RT @BrendonStilesMD: T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding inc…
RT @BrendonStilesMD: T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding inc…
T3. Great article in @NEJM last month regarding advances in lung cancer treatment. Mortality decreases exceeding incidence decreases, largely due to targeted therapy. #lcsm https://t.co/AUfocXGLyA
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
RT @stacywgray: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
@rweichselbaum The first real chemoRT sockdolager was Calais H&N, around 1999 as I recall. 20+y ago! You mentioned NEJM (see below). What hath IGRT or chemoRT (old hat) wrought? Surv impr like this? We must be brutally honest about strengths/weaknesses
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/UHXTMMxa3H
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/L1WCFRhCEl
RT @nuria_dios: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/jLuiHO6kC3
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
US pop.-based mortality rate from non–small-cell #lungcancer (NSCLC) "sharply" declined between 2013 and 2016. Survival substantially increased. ~Reason: "targeted therapies." SCLC: didn't really budge. Decreased smoking incidence played big role too. htt
RT @AmiBPatelMD: Today was #FellowsJournalClub @huntsmancancer! Here are the @NEJM papers @ChrisNevala and @WAkerleyMD discussed. Thank yo…
Today was #FellowsJournalClub @huntsmancancer! Here are the @NEJM papers @ChrisNevala and @WAkerleyMD discussed. Thank you both! Happy reading! @UtahHemeOnc https://t.co/KADgm7FGlX https://t.co/6yLXWBXiJY
The Effect of #Advances in #Lung_Cancer #Treatment on Population #Mortality | NEJM https://t.co/XtYsttIe2X
Lung cancer mortality is finally decreasing. #lcsm #lungcancer #nsclc #cancersurvivor
RT @atscommunity: Effect of advances in #lungcancer treatment on population mortality: https://t.co/XLog7PHDMN
RT @atscommunity: Effect of advances in #lungcancer treatment on population mortality: https://t.co/XLog7PHDMN
RT @atscommunity: Effect of advances in #lungcancer treatment on population mortality: https://t.co/XLog7PHDMN
Effect of advances in #lungcancer treatment on population mortality: https://t.co/XLog7PHDMN
アメリカ合衆国におけるNSCLC致死率低下は治療法の進歩によるものと示唆された。 The Effect of Advances in Lung-Cancer Treatment on Population Mortality https://t.co/DK1jhzxY6p
RT @CathyEngMD: Impact of treatment advances in ⬇️#lungcancer mortality over the past 20 yrs demonstrate the importance of #cancerresearch:…
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
RT @CathyEngMD: Impact of treatment advances in ⬇️#lungcancer mortality over the past 20 yrs demonstrate the importance of #cancerresearch:…
RT @CathyEngMD: Impact of treatment advances in ⬇️#lungcancer mortality over the past 20 yrs demonstrate the importance of #cancerresearch:…
Impact of treatment advances in ⬇️#lungcancer mortality over the past 20 yrs demonstrate the importance of #cancerresearch: https://t.co/VL4e8HNe1J @NEJM #clinicaltrials @VUMC_Cancer @VUMChealth #cancer @christine_lovly @HornLeora @NCIResearchCtr https:/
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @atscommunity: Effect of advances in #lungcancer treatment on population mortality: https://t.co/XLog7PHDMN
RT @atscommunity: Effect of advances in #lungcancer treatment on population mortality: https://t.co/XLog7PHDMN
Effect of advances in #lungcancer treatment on population mortality: https://t.co/XLog7PHDMN
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @BairdAM: The Effect of Advances in Lung-Cancer Treatment on Population Mortality https://t.co/aSYJXugQjk @NEJM #LCSM #ResearchSavesLive…
【肺がん】 非小細胞肺がんによる死亡率は急激に低下し、診断後の生存率は大幅に改善。分子標的治療薬の承認と使用の影響の可能性が高い。 対照的に小細胞がんでは生存率の改善は見られず。 米国の2013-2016年の研究。 分子標的薬の目覚ましい進歩によりますね。 https://t.co/kGihXeqboK
RT @BairdAM: The Effect of Advances in Lung-Cancer Treatment on Population Mortality https://t.co/aSYJXugQjk @NEJM #LCSM #ResearchSavesLive…
The Effect of Advances in Lung-Cancer Treatment on Population Mortality https://t.co/aSYJXugQjk @NEJM #LCSM #ResearchSavesLives #OncoAlert
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/COMS2gcNQh
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
LUNG [2]: SCLC mortality is also decreasing; however, this decrease is in line with decreasing incidence, indicating that survival for individuals with SCLC has not improved (data up to 2016). https://t.co/QDsa8wr3X0
LUNG [1]: US registry data (SEER) identify consistently decreasing mortality from NSCLC in recent years; this is only partly explained by decreasing incidence, indicating that improved therapies are impacting survival. https://t.co/QDsa8wr3X0
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @prat_aleix: valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listenin…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
Targeted therapy is one of the most promising concepts in modern medicine. It looks like it's having an impact on one of the most difficult cancers to treat. https://t.co/mlzKkW2Sbk